Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.62
0.00 (0.00%)
At close: Aug 20, 2025, 3:59 PM
3.62
0.00%
After-hours: Aug 20, 2025, 04:48 PM EDT

Altimmune Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
36.93M 135.12M 111.1M 190.3M
Short-Term Investments
94.97M 62.7M 73.78M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.64M n/a 19K 73.77K
Receivables
3.12M 4.85M 2.54M 5.84M
Inventory
n/a n/a 34K n/a
Other Current Assets
2.25M 41K n/a 34.12K
Total Current Assets
137.25M 209.63M 192.81M 204.13M
Property-Plant & Equipment
413K 1.01M 1.68M 2.25M
Goodwill & Intangibles
n/a n/a 12.42M 12.42M
Total Long-Term Assets
2.05M 1.01M 14.12M 14.74M
Total Assets
139.31M 210.64M 206.93M 218.86M
Account Payables
211K 2.07M 4.8M 2.03M
Deferred Revenue
n/a n/a n/a 9.74M
Short-Term Debt
279K 496K 452K 411.45K
Other Current Liabilities
-279K -496K 7.22M -4.06M
Total Current Liabilities
10.47M 12.14M 17.05M 18.28M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
3.93M 4.22M 3.91M 330K
Total Long-Term Liabilities
5.33M 4.4M 4.58M 1.45M
Total Liabilities
15.8M 16.54M 21.64M 19.73M
Total Debt
1.68M 671K 1.12M 1.53M
Common Stock
7K 7K 5K 4.09K
Retained Earnings
-561.39M -466.33M -377.88M -293.17M
Comprehensive Income
-4.97M -5M -5.23M -5.04M
Shareholders Equity
123.51M 194.1M 185.29M 199.13M
Total Investments
94.97M 62.7M 73.78M n/a